Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2012

Open Access 01-12-2012 | Research article

Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study

Authors: Alicia K Gerke, Ming Yang, Fan Tang, Joseph E Cavanaugh, Philip M Polgreen

Published in: BMC Pulmonary Medicine | Issue 1/2012

Login to get access

Abstract

Background

Diagnostic and treatment approaches for sarcoidosis have changed dramatically over the past decade. Yet, the most recent reports of trends in hospitalizations of sarcoidosis patients are over ten years old. The objectives of this study were to determine the incidence of sarcoidosis among hospitalized patients and to analyze recent trends and seasonality of hospitalizations in sarcoidosis patients.

Methods

We performed a retrospective cohort study of the Nationwide Inpatient Sample from 1998 through 2008. We identified all hospitalizations with a primary or secondary diagnosis of sarcoidosis (ICD-9-CM code 135). Incidence was modeled as a seasonal time series about a linear trend.

Results

Time series analysis of the monthly number of hospitalizations revealed a distinct positive linear trend. Over the study period, the number of hospitalized patients with sarcoidosis increased from 37,516 to 70,947 cases. Trends were most pronounced in patients older than 55 years (p < 0.0001), African Americans (p < 0.0001), females (p = 0.0289), and non-Medicaid populations (p < 0.0001). Hospitalizations are seasonal with highest incidence in January through March.

Conclusions

Hospitalizations among sarcoidosis patients have almost doubled during the past decade, with disproportionate rate increases in African Americans, women, and older patients. The rate also increases among patients with insurance other than Medicaid. This study indicates the need for heightened surveillance of sarcoidosis patients given the unknown consequences of evolving treatment approaches. Our results point to a need for research investigating risk factors for hospitalization, including medications, co-morbidities, demographics, and socioeconomic status.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chen ES, Moller DR: Etiology of sarcoidosis. Clin Chest Med. 2008, 29: 365-377. 10.1016/j.ccm.2008.03.011.CrossRefPubMed Chen ES, Moller DR: Etiology of sarcoidosis. Clin Chest Med. 2008, 29: 365-377. 10.1016/j.ccm.2008.03.011.CrossRefPubMed
2.
go back to reference Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999, 160: 736-755.CrossRef Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999, 160: 736-755.CrossRef
3.
go back to reference Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R: Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001, 164: 1885-1889.CrossRefPubMed Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R: Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001, 164: 1885-1889.CrossRefPubMed
4.
go back to reference Westney GE, Judson MA: Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med. 2006, 27: 453-462. 10.1016/j.ccm.2006.04.002.CrossRefPubMed Westney GE, Judson MA: Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med. 2006, 27: 453-462. 10.1016/j.ccm.2006.04.002.CrossRefPubMed
5.
go back to reference Gorham ED, Garland CF, Garland FC, Kaiser K, Travis WD, Centeno JA: Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: a 27-year historical prospective study, 1975–2001. Chest. 2004, 126: 1431-1438. 10.1378/chest.126.5.1431.CrossRefPubMed Gorham ED, Garland CF, Garland FC, Kaiser K, Travis WD, Centeno JA: Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: a 27-year historical prospective study, 1975–2001. Chest. 2004, 126: 1431-1438. 10.1378/chest.126.5.1431.CrossRefPubMed
6.
go back to reference Foreman MG, Mannino DM, Kamugisha L, Westney GE: Hospitalization for patients with sarcoidosis: 1979–2000. Sarcoidosis Vasc Diffuse Lung Dis. 2006, 23: 124-129.PubMed Foreman MG, Mannino DM, Kamugisha L, Westney GE: Hospitalization for patients with sarcoidosis: 1979–2000. Sarcoidosis Vasc Diffuse Lung Dis. 2006, 23: 124-129.PubMed
7.
go back to reference Baughman RP, Lower EE: Novel therapies for sarcoidosis. Semin Respir Crit Care Med. 2007, 28: 128-133. 10.1055/s-2007-970338.CrossRefPubMed Baughman RP, Lower EE: Novel therapies for sarcoidosis. Semin Respir Crit Care Med. 2007, 28: 128-133. 10.1055/s-2007-970338.CrossRefPubMed
8.
go back to reference Balan A, Hoey ET, Sheerin F, Lakkaraju A, Chowdhury FU: Multi-technique imaging of sarcoidosis. Clin Radiol. 2010, 65: 750-760. 10.1016/j.crad.2010.03.014.CrossRefPubMed Balan A, Hoey ET, Sheerin F, Lakkaraju A, Chowdhury FU: Multi-technique imaging of sarcoidosis. Clin Radiol. 2010, 65: 750-760. 10.1016/j.crad.2010.03.014.CrossRefPubMed
9.
go back to reference Muller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U: Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J. 1999, 14: 1117-1122. 10.1183/09031936.99.14511179.CrossRefPubMed Muller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U: Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J. 1999, 14: 1117-1122. 10.1183/09031936.99.14511179.CrossRefPubMed
10.
go back to reference Baughman RP, Winget DB, Lower EE: Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis. 2000, 17: 60-66.PubMed Baughman RP, Winget DB, Lower EE: Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis. 2000, 17: 60-66.PubMed
11.
go back to reference Judson MA, Baughman RP, Costabel U, Flavin S, Lo KH, Kavuru MS, Drent M: Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008, 31: 1189-1196. 10.1183/09031936.00051907.CrossRefPubMed Judson MA, Baughman RP, Costabel U, Flavin S, Lo KH, Kavuru MS, Drent M: Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008, 31: 1189-1196. 10.1183/09031936.00051907.CrossRefPubMed
12.
go back to reference Rossman MD, Newman LS, Baughman RP, Teirstein A, Weinberger SE, Miller W, Sands BE: A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2006, 23: 201-208.PubMed Rossman MD, Newman LS, Baughman RP, Teirstein A, Weinberger SE, Miller W, Sands BE: A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2006, 23: 201-208.PubMed
13.
go back to reference Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, Albera C, Brutsche M, Davis G, Donohue JF, Muller-Quernheim J, Schlender-Herceg R, Flavin S, Lo KH, Oemar B, Barnathan ES: Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006, 174: 795-802. 10.1164/rccm.200603-402OC.CrossRefPubMed Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, Albera C, Brutsche M, Davis G, Donohue JF, Muller-Quernheim J, Schlender-Herceg R, Flavin S, Lo KH, Oemar B, Barnathan ES: Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006, 174: 795-802. 10.1164/rccm.200603-402OC.CrossRefPubMed
14.
go back to reference Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, Brown KK: Sarcoidosis-related Mortality in the U.S. from 1988–2007. Am J Respir Crit Care Med. 2011, 183: 1524-1530. 10.1164/rccm.201010-1679OC.CrossRefPubMedPubMedCentral Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, Brown KK: Sarcoidosis-related Mortality in the U.S. from 1988–2007. Am J Respir Crit Care Med. 2011, 183: 1524-1530. 10.1164/rccm.201010-1679OC.CrossRefPubMedPubMedCentral
16.
go back to reference Rybicki BA, Major M, Popovich J, Maliarik MJ, Iannuzzi MC: Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997, 145: 234-241. 10.1093/oxfordjournals.aje.a009096.CrossRefPubMed Rybicki BA, Major M, Popovich J, Maliarik MJ, Iannuzzi MC: Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997, 145: 234-241. 10.1093/oxfordjournals.aje.a009096.CrossRefPubMed
17.
go back to reference James DG, Neville E, Siltzbach LE: A worldwide review of sarcoidosis. Ann N Y Acad Sci. 1976, 278: 321-334. 10.1111/j.1749-6632.1976.tb47043.x.CrossRefPubMed James DG, Neville E, Siltzbach LE: A worldwide review of sarcoidosis. Ann N Y Acad Sci. 1976, 278: 321-334. 10.1111/j.1749-6632.1976.tb47043.x.CrossRefPubMed
18.
go back to reference Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT: The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol. 1986, 123: 840-845.PubMed Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT: The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol. 1986, 123: 840-845.PubMed
19.
go back to reference Gornick ME, Eggers PW, Reilly TW, Mentnech RM, Fitterman LK, Kucken LE, Vladeck BC: Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med. 1996, 335: 791-799. 10.1056/NEJM199609123351106.CrossRefPubMed Gornick ME, Eggers PW, Reilly TW, Mentnech RM, Fitterman LK, Kucken LE, Vladeck BC: Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med. 1996, 335: 791-799. 10.1056/NEJM199609123351106.CrossRefPubMed
20.
go back to reference Chang B, Steimel J, Moller DR, Baughman RP, Judson MA, Yeager H, Teirstein AS, Rossman MD, Rand CS: Depression in sarcoidosis. Am J Respir Crit Care Med. 2001, 163: 329-334.CrossRefPubMed Chang B, Steimel J, Moller DR, Baughman RP, Judson MA, Yeager H, Teirstein AS, Rossman MD, Rand CS: Depression in sarcoidosis. Am J Respir Crit Care Med. 2001, 163: 329-334.CrossRefPubMed
21.
go back to reference Rabin DL, Thompson B, Brown KM, Judson MA, Huang X, Lackland DT, Knatterud GL, Yeager H, Rose C, Steimel J: Sarcoidosis: social predictors of severity at presentation. Eur Respir J. 2004, 24: 601-608. 10.1183/09031936.04.00070503.CrossRefPubMed Rabin DL, Thompson B, Brown KM, Judson MA, Huang X, Lackland DT, Knatterud GL, Yeager H, Rose C, Steimel J: Sarcoidosis: social predictors of severity at presentation. Eur Respir J. 2004, 24: 601-608. 10.1183/09031936.04.00070503.CrossRefPubMed
22.
go back to reference Ligon CB, Judson MA: Impact of systemic corticosteroids on healthcare utilization in pateints with sarcoidosis. Am J Med Sci. 2011, 341: 196-201. 10.1097/MAJ.0b013e3181fe3eb2.CrossRefPubMed Ligon CB, Judson MA: Impact of systemic corticosteroids on healthcare utilization in pateints with sarcoidosis. Am J Med Sci. 2011, 341: 196-201. 10.1097/MAJ.0b013e3181fe3eb2.CrossRefPubMed
23.
go back to reference Nguyen GC, Tuskey A, Dassopoulos T, Harris ML, Brant SR: Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis. 2007, 13: 1529-1535. 10.1002/ibd.20250.CrossRefPubMed Nguyen GC, Tuskey A, Dassopoulos T, Harris ML, Brant SR: Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis. 2007, 13: 1529-1535. 10.1002/ibd.20250.CrossRefPubMed
24.
go back to reference Cannom RR, Kaiser AM, Ault GT, Beart RW, Etzioni DA: Inflammatory bowel disease in the United States from 1998 to 2005: has infliximab affected surgical rates?. Am Surg. 2009, 75: 1039-1045. Cannom RR, Kaiser AM, Ault GT, Beart RW, Etzioni DA: Inflammatory bowel disease in the United States from 1998 to 2005: has infliximab affected surgical rates?. Am Surg. 2009, 75: 1039-1045.
25.
go back to reference Demirkok SS, Basaranoglu M, Akbilgic O: Seasonal variation of the onset of presentations in stage 1 sarcoidosis. Int J Clin Pract. 2006, 60: 1443-1450. 10.1111/j.1742-1241.2006.00773.x.CrossRefPubMed Demirkok SS, Basaranoglu M, Akbilgic O: Seasonal variation of the onset of presentations in stage 1 sarcoidosis. Int J Clin Pract. 2006, 60: 1443-1450. 10.1111/j.1742-1241.2006.00773.x.CrossRefPubMed
26.
go back to reference Wilsher ML: Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur Respir J. 1998, 12: 1197-1199. 10.1183/09031936.98.12051197.CrossRefPubMed Wilsher ML: Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur Respir J. 1998, 12: 1197-1199. 10.1183/09031936.98.12051197.CrossRefPubMed
27.
go back to reference Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ: Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006, 61: 980-985. 10.1136/thx.2006.062836.CrossRefPubMedPubMedCentral Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ: Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006, 61: 980-985. 10.1136/thx.2006.062836.CrossRefPubMedPubMedCentral
28.
go back to reference Gillman A, Steinfort C: Sarcoidosis in Australia. Intern Med J. 2007, 37: 356-359. 10.1111/j.1445-5994.2007.01365.x.CrossRefPubMed Gillman A, Steinfort C: Sarcoidosis in Australia. Intern Med J. 2007, 37: 356-359. 10.1111/j.1445-5994.2007.01365.x.CrossRefPubMed
Metadata
Title
Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study
Authors
Alicia K Gerke
Ming Yang
Fan Tang
Joseph E Cavanaugh
Philip M Polgreen
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2012
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-12-19

Other articles of this Issue 1/2012

BMC Pulmonary Medicine 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.